Product Description

Librela^­™ is a sterile injectable solution that is indicated for the control of pain associated with osteoarthritis (OA) in dogs. It is the first and only monthly injectable anti-nerve growth factor monoclonal antibody therapy for the control of canine OA pain.

Features & Benefits

• Effectively controls canine OA pain with a monthly injection
• Approved as safe and is metabolized and eliminated like naturally occurring antibodies, with minimal involvement of the liver or kidneys
• Works differently than NSAIDs by reducing NGF effects, a key factor in canine OA pain
• Reduced canine OA pain, which led to increased activity and improved quality of life